Trials / Completed
CompletedNCT02314689
A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Suvankar Majumdar · Academic / Other
- Sex
- All
- Age
- 18 Years – 25 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the maximum tolerated dose, safety and pharmacokinetics of an investigational drug, intravenous (IV) citrulline, in subjects in steady-state sickle cell disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous (IV) citrulline |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- Completion
- 2015-12-01
- First posted
- 2014-12-11
- Last updated
- 2019-09-03
- Results posted
- 2016-03-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02314689. Inclusion in this directory is not an endorsement.